2型糖尿病患者泛血管疾病风险评估与管理 中国专家共识（2022版）.

Panvascular disease is not only a common comorbidity of type 2 diabetes mellitus (T2DM), but also the leading cause of disability and death in patients with T2DM. To promote multidisciplinary cooperation, interdisciplinary integration, and early detection of panvascular diseases in T2DM patients, a panel composed of Chinese experts in cardiovascular disease, endocrinology, nephrology, neurology, and health management led by Chinese College of Cardiovascular Physicians was established and developed this consensus based on the latest evidence‑based medical research and crucial progress in the related disciplines. This consensus covers the epidemiological characteristics, pathophysiological mechanisms, multidisciplinary collaborative diagnosis and treatment, as well as risk assessment and management, and highlights the early risk assessment of panvascular disease in patients with T2DM (assess risk factors, vascular structure and function, and target organ damage at least annually). This consensus also emphasizes that managing panvascular disease in patients with T2DM requires the participation of both patients and multidisciplinary physicians and the necessity of strengthening the control of blood glucose, blood pressure, blood lipids, and antiplatelet therapy based on lifestyle interventions. The consensus will standardize the comprehensive clinical management of panvascular disease in patients with T2DM and improve patient prognosis. [ABSTRACT FROM AUTHOR]